BioLargo, Inc. (BLGO) Reports Q4 results

BioLargo, Inc. (OTC: BLGO) reported Q4 Revenue for the quarter at $4.4 million versus the consensus estimate of $3.47 million.

For earnings history and earnings-related data on BioLargo, Inc. (BLGO) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c